GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
436
c/glp1eu·posted 2 years ago by u/nordic_pricing

Apotheke — 10 things I got wrong before I got it right

Pricing Slow Clap ×8

Apotheke — 10 things I got wrong before I got it right, and I am aware this is a minority view on this board.

Pharmacy margins and dispensing fees are regulated nationally, which explains price differences that otherwise look arbitrary.

Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.

Supply notices are issued nationally. A notice in one member state does not imply availability problems in another, even for the same product.

Please do not ask me what dose you should be on. I genuinely do not know and neither does anyone else here.

676 up / 240 down74% upvoted23 commentsid 1ykguk21 Jun 2024

23 comments

21 in this archive, depth 5

best — the order this archive was captured in

u/enzo_petrescu67 points·2 years ago

Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.

replysharereportpermalink
[removed]48 points·2 years ago

[removed by moderator]

replysharereportpermalink
u/cardio_endpoint_c-11 points·2 years ago

the reimbursement criteria are published in most member states

replysharereportpermalink
u/tobias_vukovic22 points·2 years ago

Right, and a shortage notice in one country tells you very little about the next one along.

replysharereportpermalink
u/gallbladder_gary8 points·2 years ago

the language barrier is a real cost and nobody budgets for it

replysharereportpermalink
u/ignacio_silva15 points·2 years ago

Marketing authorisation is granted centrally for these products; reimbursement, pricing and prescribing criteria are national competences. Those are decided by different bodies with different processes.

replysharereportpermalink
u/erez_yilmaz5 points·2 years ago

the same product has different names and pack sizes across the union

replysharereportpermalink
u/throwaway_44b13 points·2 years ago·edited

Yes. Pack sizes differ enough that per-month price comparisons across borders need to be normalised before they mean anything.

replysharereportpermalink
u/nordic_pricingOP2 points·2 years ago

Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.

replysharereportpermalink
u/oskar_malinowski18 points·2 years ago

Compared prices across two neighbouring countries and found the difference was mostly pack size once I normalised it.

replysharereportpermalink
u/priya_guerrero30 points·2 years ago

Is this a cross-border question or a domestic one?

replysharereportpermalink
u/tobias_vukovic21 points·2 years ago

Reimbursed or private?

replysharereportpermalink
u/cormac_erdogan23 points·2 years ago

Pack sizes and presentations differ between member states, so a headline price is not comparable until it is normalised to a common quantity.

replysharereportpermalink
u/nordic_pricingOP13 points·2 years ago

What pack size is that price for?

replysharereportpermalink
u/chidi_demir11 points·2 years ago

That is an authorisation question and you have answered a reimbursement one. They are decided by different bodies.

replysharereportpermalink
u/rania_marchand3 points·2 years ago

The translation cost of dealing with a foreign pharmacy was the thing I had not budgeted for.

replysharereportpermalink
load more comments (5) →
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.